Skip to content

Lhermitte-Duclos Disease (LDD) & Hermansky-Pudlak Syndrome (HPS)

Lhermitte-Duclos Disease (LDD) and Its Association with Cowden Syndrome

  • Lhermitte-Duclos Disease (LDD) is a rare, slow-growing cerebellar tumor, specifically a dysplastic gangliocytoma. It manifests as:
    • Enlarged cerebellum.
    • Increased intracranial pressure.
    • Symptoms like headache, ataxia, and visual disturbances.
  • Association with Cowden Syndrome:
    • Cowden Syndrome (CS) is a genetic disorder caused by mutations in the PTEN gene, which is a tumor suppressor.
    • Cowden Syndrome is characterized by multiple hamartomas and increased risk for breast, thyroid, and endometrial cancers.
    • Lhermitte-Duclos Disease is considered a hallmark feature of Cowden Syndrome. It may present as part of this syndrome, indicating a predisposition to malignancies.
    • Screening for Cowden Syndrome is critical when diagnosing LDD due to the increased cancer risks associated with PTEN mutations.

Hermansky-Pudlak Syndrome (HPS) and Its Association with Inflammatory Bowel Disease (IBD)

  • Hermansky-Pudlak Syndrome (HPS) is a rare genetic disorder characterized by:
    • Oculocutaneous albinism (light skin, hair, and eyes).
    • Platelet dysfunction leading to bleeding diathesis.
    • Lung fibrosis, and granulomatous colitis.
    • It is caused by mutations in one of several genes involved in lysosome-related organelles formation and function.
  • Association with Inflammatory Bowel Disease (IBD):
    • Many patients with HPS, especially those with specific gene mutations (e.g., HPS1, HPS4), develop granulomatous colitis, which is a form of IBD.
    • The colitis seen in HPS can resemble Crohn's disease in its presentation, with similar gastrointestinal symptoms like diarrhea, abdominal pain, and weight loss.
    • Treatment often includes anti-inflammatory and immunosuppressive therapies similar to those used for IBD, but the colitis in HPS can be more refractory to treatment.

In both cases, genetic mutations lead to systemic effects, with Cowden Syndrome predisposing to cancers and HPS involving multisystemic effects, including a specific form of IBD.